Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1065 | 0.1065 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.0319 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1065 | 0.1065 |
Mycobacterium ulcerans | transmembrane cation transporter | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0308 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.0319 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.1065 | 0.1065 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0293 | 0.9487 | 0.9487 |
Schistosoma mansoni | hypothetical protein | 0.0308 | 1 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.002 | 0.0174 | 0.1414 |
Entamoeba histolytica | calcium-gated potassium channel protein, putative | 0.0015 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0039 | 0.0805 | 0.0805 |
Loa Loa (eye worm) | hypothetical protein | 0.0308 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0154 | 0.4758 | 0.4758 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0319 | 0.0319 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0138 | 0.4217 | 0.4217 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0039 | 0.0805 | 0.0805 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.002 | 0.0174 | 0.1414 |
Mycobacterium ulcerans | ion transport protein | 0.0015 | 0 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0024 | 0.0319 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.0319 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0039 | 0.0805 | 0.7556 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.0308 | 1 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0024 | 0.0319 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1065 | 0.1065 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1065 | 0.1065 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0042 | 0.0926 | 0.0926 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.1065 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.1065 | 0.1065 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0051 | 0.1231 | 1 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0024 | 0.0319 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.1065 | 0.1065 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0631 | 0.0631 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.1065 | 0.1065 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0319 | 0.2999 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Mycobacterium tuberculosis | Possible transmembrane cation transporter | 0.0015 | 0 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0039 | 0.0805 | 0.0805 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Onchocerca volvulus | 0.0015 | 0 | 0.5 | |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0051 | 0.1231 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.0319 | 1 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0025 | 0.0231 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0024 | 0.0319 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0042 | 0.0926 | 0.0926 |
Onchocerca volvulus | 0.0015 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | In vivo inhibitory activity against LTB4-induced bronchoconstriction of guinea pig at dose of 5 mg/kg after 2 min of iv administration; Not Tested | ChEMBL. | No reference |
Activity (functional) | NT 0 | In vivo inhibitory activity against LTB4-induced bronchoconstriction of guinea pig at dose of 5 mg/kg after 10 min of iv administration; Negative | ChEMBL. | No reference |
Activity (functional) | 0 | In vivo inhibitory activity against LTB4-induced bronchoconstriction of guinea pig at dose of 5 mg/kg after 30 min of iv administration; Not Tested | ChEMBL. | No reference |
Activity (functional) | 0 | In vivo inhibitory activity against LTB4-induced bronchoconstriction of guinea pig at dose of 40 mg/kg after 60 min of po administration; Not Tested | ChEMBL. | No reference |
IC50 (functional) | = 0.8 uM | Concentration required for inhibitory activity against human PMNLs chemotaxis | ChEMBL. | No reference |
IC50 (functional) | = 0.8 uM | Concentration required for inhibitory activity against human PMNLs chemotaxis | ChEMBL. | No reference |
logD | = 1.1 | Partition coefficient of the compound was determined in n-octanol/phosphate buffer, at pH 7.4 | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.